ORITAVANCIN DIPHOSPHATE

ORITAVANCIN DIPHOSPHATE was reported 297 times

ORITAVANCIN DIPHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE JOINT SWELLING 1 0.1667
1 VANCOMYCIN INFUSION REACTION 12 0.0318
2 MULTIPLE USE OF SINGLE-USE PRODUCT 109 0.0194
3 PERFORATION BILE DUCT 1 0.0077
4 PNEUMONITIS CHEMICAL 2 0.0057
5 HYPERTENSIVE URGENCY 1 0.0018
6 JARISCH-HERXHEIMER REACTION 1 0.0014
7 GRIMACING 1 0.0013
8 INFUSION RELATED REACTION 67 0.0010
9 MYOCARDIAL INJURY 1 0.0009
10 PRURITUS ALLERGIC 1 0.0009
11 REFLUX GASTRITIS 1 0.0008
12 CHILLS 92 0.0008
13 INFUSION SITE RASH 1 0.0007
14 INFUSION SITE EXTRAVASATION 4 0.0006
15 FEELING COLD 17 0.0006
16 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
17 AKINESIA 1 0.0005
18 LIVEDO RETICULARIS 1 0.0005
19 ORAL PRURITUS 1 0.0004
20 INGROWING NAIL 1 0.0004
21 VASODILATATION 1 0.0004
22 CANCER PAIN 1 0.0004
23 CYANOSIS 6 0.0004
24 FLUSHING 35 0.0003
25 INFUSION SITE REACTION 1 0.0003
26 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
27 INFUSION SITE SWELLING 2 0.0003
28 LIVER ABSCESS 1 0.0003
29 POSTURE ABNORMAL 1 0.0003
30 PERIPHERAL COLDNESS 4 0.0003
31 HYPOPNOEA 1 0.0003
32 EXTRASYSTOLES 2 0.0003
33 THROMBOPHLEBITIS 1 0.0003
34 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
35 THROAT CLEARING 1 0.0003
36 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
37 EXTRAVASATION 1 0.0002
38 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
39 INFUSION SITE PAIN 3 0.0002
40 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
41 TREMOR 36 0.0002
42 FLANK PAIN 2 0.0002
43 HYPOAESTHESIA ORAL 3 0.0002
44 DEAFNESS UNILATERAL 1 0.0002
45 DENTAL CARIES 2 0.0002
46 BACK PAIN 42 0.0002
47 SKIN IRRITATION 8 0.0002
48 COLD SWEAT 3 0.0002
49 WRONG PRODUCT ADMINISTERED 1 0.0001
50 HYPERTRANSAMINASAEMIA 1 0.0001
51 RETCHING 3 0.0001
52 PARAESTHESIA ORAL 2 0.0001
53 FEELING DRUNK 1 0.0001
54 CHEST PAIN 24 0.0001
55 NECK PAIN 7 0.0001
56 MUSCLE TIGHTNESS 2 0.0001
57 POST PROCEDURAL INFECTION 1 0.0001
58 INFUSION SITE ERYTHEMA 1 0.0001
59 MUSCULOSKELETAL DISCOMFORT 2 0.0001
60 OROPHARYNGEAL DISCOMFORT 1 0.0001
61 ERUCTATION 2 0.0001
62 DIZZINESS POSTURAL 1 0.0001
63 FEELING HOT 6 0.0001
64 CHEST DISCOMFORT 10 0.0001
65 VENTRICULAR EXTRASYSTOLES 1 0.0001
66 PRURITUS 37 0.0001
67 FULL BLOOD COUNT ABNORMAL 1 0.0001
68 HYPERHIDROSIS 12 0.0001
69 TACHYCARDIA 8 0.0001
70 HYPERTENSIVE CRISIS 1 0.0001
71 OXYGEN SATURATION DECREASED 5 0.0001
72 MYOCARDIAL ISCHAEMIA 1 0.0001
73 HYPOXIA 3 0.0001
74 BACTERAEMIA 1 0.0001
75 ERYTHEMA 17 0.0001
76 URTICARIA 13 0.0001
77 ADVERSE REACTION 1 0.0001
78 THROAT TIGHTNESS 2 0.0001
79 TACHYPNOEA 1 0.0001
80 PALLOR 2 0.0001
81 CORONARY ARTERY OCCLUSION 1 0.0001
82 MASS 1 0.0001
83 BRONCHOSPASM 1 0.0001
84 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
85 DYSPNOEA 38 0.0001
86 IMMUNODEFICIENCY 1 0.0001
87 PULMONARY OEDEMA 3 0.0001
88 THROAT IRRITATION 3 0.0001
89 DISCOMFORT 4 0.0001
90 LIMB DISCOMFORT 2 0.0001
91 BASAL CELL CARCINOMA 1 0.0001
92 BLOOD POTASSIUM INCREASED 1 0.0001
93 BLOOD PRESSURE DECREASED 4 0.0001
94 HYPERSENSITIVITY 11 0.0001
95 RASH 25 0.0001
96 EOSINOPHILIA 1 0.0001
97 OFF LABEL USE 49 0.0001
98 PELVIC PAIN 1 0.0001
99 CRYING 2 0.0001
100 BONE DISORDER 1 0.0001
101 MUSCLE SPASMS 10 0.0001
102 ANAPHYLACTIC REACTION 3 0.0001
103 BLOOD PRESSURE INCREASED 8 0.0001
104 ACUTE RESPIRATORY FAILURE 1 0.0001
105 NASAL CONGESTION 3 0.0001
106 BLOOD PRESSURE ABNORMAL 1 0.0001
107 HYPOTENSION 10 0.0000
108 PRODUCT ADMINISTRATION ERROR 1 0.0000
109 BODY TEMPERATURE INCREASED 1 0.0000
110 VOMITING 23 0.0000
111 SNEEZING 1 0.0000
112 HEART RATE IRREGULAR 1 0.0000
113 NAUSEA 35 0.0000
114 BLOOD PRESSURE FLUCTUATION 1 0.0000
115 PRESYNCOPE 1 0.0000
116 HEART RATE INCREASED 4 0.0000
117 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
118 UNRESPONSIVE TO STIMULI 1 0.0000
119 INFLUENZA LIKE ILLNESS 3 0.0000
120 MENTAL STATUS CHANGES 1 0.0000
121 ARTHROPATHY 2 0.0000
122 SEPSIS 4 0.0000
123 WHEEZING 2 0.0000
124 LACRIMATION INCREASED 1 0.0000
125 SWELLING 3 0.0000
126 HEAD INJURY 1 0.0000
127 EYE PRURITUS 1 0.0000
128 PRODUCT QUALITY ISSUE 4 0.0000
129 HEART RATE DECREASED 1 0.0000
130 PANIC ATTACK 1 0.0000
131 RESTLESSNESS 1 0.0000
132 INJECTION SITE MASS 1 0.0000
133 DYSARTHRIA 1 0.0000
134 DISORIENTATION 1 0.0000
135 CARDIAC ARREST 2 0.0000
136 CARDIO-RESPIRATORY ARREST 1 0.0000
137 LOSS OF CONSCIOUSNESS 3 0.0000
138 HEADACHE 14 0.0000
139 VISION BLURRED 3 0.0000
140 TINNITUS 1 0.0000
141 OCULAR HYPERAEMIA 1 0.0000
142 PYREXIA 7 0.0000
143 LEUKOPENIA 1 0.0000
144 CELLULITIS 1 0.0000
145 ACUTE KIDNEY INJURY 3 0.0000
146 PERIPHERAL SWELLING 3 0.0000
147 NERVOUSNESS 1 0.0000
148 PANCREATITIS 1 0.0000
149 BRADYCARDIA 1 0.0000
150 ASTHENIA 7 0.0000
151 RASH PRURITIC 1 0.0000
152 TREATMENT NONCOMPLIANCE 1 0.0000
153 DIZZINESS 9 0.0000
154 PANCYTOPENIA 1 0.0000
155 ASTHMA 2 0.0000
156 INCORRECT DOSE ADMINISTERED 4 0.0000
157 LETHARGY 1 0.0000
158 SEIZURE 2 0.0000
159 FEELING ABNORMAL 4 0.0000
160 INJECTION SITE REACTION 1 0.0000
161 BURNING SENSATION 1 0.0000
162 SLEEP DISORDER 1 0.0000
163 HOT FLUSH 1 0.0000
164 PAIN 8 0.0000
165 PARAESTHESIA 2 0.0000
166 THROMBOSIS 1 0.0000
167 ARTHRALGIA 5 0.0000
168 MYOCARDIAL INFARCTION 2 0.0000
169 ADVERSE DRUG REACTION 1 0.0000
170 ADVERSE EVENT 1 0.0000
171 PULMONARY EMBOLISM 1 0.0000
172 CONTUSION 1 0.0000
173 ATRIAL FIBRILLATION 1 0.0000
174 DYSPEPSIA 1 0.0000
175 SYNCOPE 1 0.0000
176 SOMNOLENCE 2 0.0000
177 THROMBOCYTOPENIA 1 0.0000
178 MUSCULAR WEAKNESS 1 0.0000
179 ABDOMINAL PAIN 2 0.0000
180 PALPITATIONS 1 0.0000
181 OEDEMA PERIPHERAL 1 0.0000
182 NEUTROPENIA 1 0.0000
183 COUGH 2 0.0000
184 INFECTION 1 0.0000
185 MALAISE 3 0.0000
186 PAIN IN EXTREMITY 2 0.0000
187 INJECTION SITE PAIN 2 0.0000
188 HOSPITALISATION 1 0.0000
189 MYALGIA 1 0.0000
190 BLOOD GLUCOSE INCREASED 1 0.0000
191 ANAEMIA 1 0.0000
192 ABDOMINAL PAIN UPPER 1 0.0000
193 HYPERTENSION 1 0.0000
194 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
195 ANXIETY 1 0.0000
196 CONDITION AGGRAVATED 1 0.0000
197 DIARRHOEA 2 0.0000
198 PNEUMONIA 1 0.0000
199 DEATH 2 0.0000
200 FATIGUE 1 0.0000
201 DRUG INEFFECTIVE 1 0.0000